Analytical and preanalytical validation of a new mass spectrometric serum 5-hydroxyindoleacetic acid assay as neuroendocrine tumor marker

Clinica Chimica Acta

Volumn 428, Issue , 2014, Pages 38-43

  Tohmola, Niina ^a   Itkonen, Outi ^b   Sane, Timo ^b   Markkanen, Helene ^b   Joenväärä, Sakari ^a   Renkonen, Risto ^a,b   Hämäläinen, Esa ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

5 Hydroxyindoleacetic acid; Chromogranin A; LC MS MS; Neuroendocrine tumor

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A; SEROTONIN; TRYPTOPHAN; TUMOR MARKER; VANILMANDELIC ACID;

ADULT; AGED; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TEMPERATURE DEPENDENCE; VALIDATION PROCESS; ADOLESCENT; BLOOD; MIDDLE AGED; NEUROENDOCRINE TUMORS; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEUROENDOCRINE TUMORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84888058217     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.10.025     Document Type: Article

References (29)

1. Modlin I.M., Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 2000, 79:813-829.
2. Williams E., Sandler M. The classification of carcinoid tumors. Lancet 1963, 1:238-239.
3. Yao J.C., Hassan M., Phan A., et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008, 26:3063-3072.
4. Zuetenhorst J.M., Taal B.G. Metastatic carcinoid tumors: a clinical review. Oncologist 2005, 10:123-131.
5. Ramage J., Davies A., Ardill J., et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005, 54(Suppl. 4):IV1-IV16.
6. O'Toole D., Grossman A., Gross D., et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers. Neuroendocrinology 2009, 90:194-202.
7. Eriksson B., Öberg K., Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000, 62:33-38.
8. Welin S., Stridsberg M., Cunningham J., et al. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors. Neuroendocrinology 2009, 89:302-307.
9. de Herder W.W. Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007, 21:33-41.
10. Janson E.T., Sørbye H., Welin S., et al. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol 2010, 49:740-756.
11. Brashear J., Zeitvogel C., Jackson J., et al. Fluorescence polarization immunoassay of urinary 5-hydroxy-3-indoleacetic acid. Clin Chem 1989, 35:355-359.
12. Davis B.A., Durden D.A., Boulton A.A. Simultaneous analysis of twelve biogenic amine metabolites in plasma, cerebrospinal fluid and urine by capillary column gas chromatography-high-resolution mass spectrometry with selected-ion monitoring. J Chromatogr B 1986, 374:227-238.
13. Mulder E.J., Oosterloo-Duinkerken A., Anderson G.M., De Vries E.G.E., Minderaa R.B., Kema I.P. Automated on-line solid-phase extraction coupled with HPLC for measurement of 5-hydroxyindole-3-acetic acid in urine. Clin Chem 2005, 51:1698-1703.
14. Lionetto L., Lostia A.M., Stigliano A., Cardelli P., Simmaco M. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid. Clin Chim Acta 2008, 398:53-56.
15. Kroll C.A., Magera M.J., Helgeson J.K., Matern D., Rinaldo P. Liquid chromatographic-tandem mass spectrometric method for the determination of 5-hydroxyindole-3-acetic acid in urine. Clin Chem 2002, 48:2049-2051.
16. Perry H., Keevil B. Online extraction of 5-hydroxyindole acetic acid from urine for analysis by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 2008, 45:149-152.
17. de Jong W.H.A., Graham K.S., de Vries E.G.E., Kema I.P. Urinary 5-HIAA measurement using automated on-line solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B 2008, 868:28-33.
18. Carling R., Degg T., Allen K., Bax N., Barth J. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002, 39:577.
19. Degg T., Allen K., Barth J. Measurement of plasma 5-hydroxyindoleacetic acid in carcinoid disease: an alternative to 24-h urine collections?. Ann Clin Biochem 2000, 37:724-726.
20. Cai H.L., Zhu R.H., Li H.D. Determination of dansylated monoamine and amino acid neurotransmitters and their metabolites in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Biochem 2010, 396:103-111.
21. Miller A.G., Brown H., Degg T., Allen K., Keevil B.G. Measurement of plasma 5-hydroxyindole acetic acid by liquid chromatography tandem mass spectrometry-comparison with HPLC methodology. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:695-699.
22. Tellez M.R., Mamikunian G., O'Dorisio T.M., Vinik A.I., Woltering E.A. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs). Pancreas 2013, 42:405-410.
23. Danaceau J.P., Anderson G.M., McMahon W.M., Crouch D.J. A liquid chromatographic-tandem mass spectrometric method for the analysis of serotonin and related indoles in human whole blood. J Anal Toxicol 2003, 27:440-444.
24. Felding P., Rustad P., Mårtensson A., et al. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004, 64:327-342.
25. Odink J., Korthals H., Knijff J. Simultaneous determination of the major acidic metabolites of catecholamines and serotonin in urine by liquid chromatography with electrochemical detection after a one-step sample clean-up on Sephadex G-10; influence of vanilla and banana ingestion. J Chromatogr B 1988, 424:273-283.
26. de Jong W.H., de Vries E.G., Kema I.P. Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines. Clin Biochem 2011, 44:95-103.
27. Pietraszek M., Takahashi S., Takada Y., et al. Diurnal patterns of serotonin, 5-hydroxyindoleacetic acid, tryptophan and fibrinolytic activity in blood of depressive patients and healthy volunteers. Thromb Res 1991, 64:243-252.
28. Sano H., Suzuki Y., Yazaki R., et al. Circadian variation in plasma 5-hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects. Acta Psychiatr Scand 2007, 87:291-296.
29. 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour. Eur J Nucl Med 2011, 38:1854-1861.